Karl Blom

Karl Blom has extensive work experience in the pharmaceutical industry. Karl currently holds the position of Executive Director of Discovery Chemistry Analytical at Prelude Therapeutics Incorporated since May 2019. Prior to that, they worked at Incyte for 16 years as a Senior Director in the same field. Karl has also held research and investigative roles at Bristol-Myers Squibb, DuPont Pharmaceuticals, DuPont Merck Pharma, and DuPont, where they gained valuable experience in various scientific roles.

Karl Blom holds a Doctor of Philosophy (PhD) in Physical Chemistry from the University of Delaware. The specific start and end years of their education at this institution are not mentioned.